As a result of this correlation, there is an interest in studying the role of upregulation in the CCR5 pathway, as evidenced by a number of clinical trials targeting CCR5 as a point of inhibition to possibly reduce the motility of cells spreading BC [3, 9–12]. The gene discussed is CCR5; the disease is breast cancer.